Loading clinical trials...
Loading clinical trials...
Brief Induction Chemoimmunotherapy With Rituximab + Bendamustine + Mitoxantrone Followed by Rituximab in Elderly Patients With Advanced Stage Previously Untreated Follicular Lymphoma
Conditions
Interventions
Rituximab, Mitoxantrone, Bendamustine
Locations
37
Italy
Divisione di Ematologia Ospedale SS. Antonio e Biagio
Alessandria, Alessandria, Italy
SOS Ematologia Ospedale C. Massaia
Asti, Asti, Italy
Ematologia con Trapianto, Università di Bari
Bari, Bari, Italy
Medicina Interna, Ospedale degli Infermi
Biella, Biella, Italy
Istituto di Ematologia ed Oncologia Medica A. Seragnoli Policlinico S. Orsola
Bologna, Bologna, Italy
Divisione di Ematologia e TMO, Ospedale di Bolzano
Bolzano, Bolzano, Italy
Start Date
June 1, 2009
Primary Completion Date
January 1, 2015
Completion Date
January 1, 2015
Last Updated
March 1, 2016
NCT06337318
NCT05006716
NCT06026319
NCT07128641
NCT06510361
NCT01804686
Lead Sponsor
Fondazione Italiana Linfomi - ETS
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions